… (3) Gefitinib and erlotinib are the first small molecule tyrosine … Ⅲ trials from Japan compared
gefitinib with platinumbased … FZKA may have sensitizing effect on gefitinib in treating …

… with advanced (III IV) stage EGFR positive in non-small cell … , compare to Gefitinib the
ICER of Erlotinib and Afatinib are … , Erlotinib and Afatinib would be more cost effectiveness to …

… To compare the efficacy and safety of gefitinib, erlotinib, and afatinib in the first-line treatment
of advanced non-small … Conclusion Erlotinib might be the preferred first-line treatment for …

… -0.970; 0.0114) for afatinib group comparing with gefitinib and erlotinib group, … compared
with gefitinib and erlotinib. Despite of the higher cost, afatinib was still a cost-effective treatment. …

… differences of efficacy of chemotherapy and epidermal growth factor receptor-tyrosine kinase
inhibitor treatment … factor for gefitinib treatment in patients with non-small cell lung cancer[J]. …

… that the effect of adjuvant therapy was obvious (9/12) . There was no significant difference
in … stay was longer, but there was no significant difference (P>0.05) ; there was significant …

… clinical efficacy of thalidomide combined with gefitinib in the … Comparison of gefitinib, erlotinib
and afatinib in non-small cell … trial of erlotinib vs gefitinib in advanced non-small cell lung …

… radiation effect in urinary bladder cancer treatment while not … -line treatment of patients with
metastatic non-small cell lung … irradiation (compared with afatinib or erlotinib treatment alone…

… 或转移性非小细胞肺癌(non-small cell lung cancer,NSCLC) 患者一线… Results Compared with
erlotinib, gefitinib, afatinib and … was more cost-effective as the first-line treatment for locally …

… Current studies have shown that there are some differences in … -TKI (erlotinib and gefitinib),
second-generation EGFR-TKI (… mutation and targeted therapy for non-small cell lung cancer. …